| Ytd | 35.96% | |
| 1y | 95.84% |
| Open | Prev Close | 40.91 | Low | High | Mkt Cap | 2.59B | |||
| Vol | 0.00 | Avg Vol | 414.61K | EPS | 1.14 | P/E | 35.89 | Forward P/E | 32.89 |
| Beta | 0.05 | Short Ratio | 6.49 | Inst. Own | 59.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 39.79 | 200-d Avg | 33.75 | 1yr Est | 47.00 |
GRDN News
Bessemer Group Inc. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE: GRDN) during th
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation’s largest and most innovative long-t
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy a
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the
Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrade
B of A Securities analyst Allen Lutz initiates coverage on Guardian Pharmacy Service (NYSE:GRDN)
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
Jefferies analyst Brian Tanquilut initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) wit
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were update
Stock futures slightly lower, Alibaba falls after downbeat earnings, other stocks decline in pre-mar
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its
Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4
US stock futures mixed on Thursday, with focus on Accenture, Micron, Alibaba's earnings. Guardia
The Offering for GRDN's Class A common stock, consisting of 3,980,000 shares being offered by ce
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.33 per share which beat the
